Induction of proliferation and monocytic differentiation of human CD34 + cells by CD137 ligand signaling

Stem Cells

Volumn 26, Issue 9, 2008, Pages 2372-2381

  Jiang, Dongsheng ^a   Yue, Pei Shan Eunice ^a   Drenkard, Daniela ^b   Schwarz, Herbert ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CD137; CD34+ cells; Hematopoiesis; Monocytes; Myeloid

Indexed keywords

CD137 LIGAND;

ARTICLE; BONE MARROW CELL; CD34 SELECTION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMING UNIT; CROSS LINKING; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONOCYTE; PHAGOCYTOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

4-1BB LIGAND; ANTIGENS, CD137; ANTIGENS, CD34; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; MONOCYTES; SIGNAL TRANSDUCTION;

EID: 55049109182     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2008-0158     Document Type: Article

References (34)

1. Schwarz H, Tuckwell J, Lotz M. A receptor induced by lymphocyte activation (ILA): A new member of the human nerve-growth-factor/ tumor-necrosis-factor receptor family. Gene 1993;134:295-298.
2. Kwon BS, Weissman SM. cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci U S A 1989;86:1963-1967.
3. Croft M. Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? Nat Rev Immunol 2003;3:609-620.
4. Sica G, Chen L. Modulation of the immune response through 4-1BB. Adv Exp Med Biol 2000;465:355-362.
5. Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005;23:23-68.
6. Mittler RS. Suppressing the self in rheumatoid arthritis. Nat Med 2004;10:1047-1049.
7. Myers LM, Vella AT. Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation. Trends Immunol 2005;26:440-446.
8. Eissner G, Kolch W, Scheurich P. Ligands working as receptors: Reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev 2004;15:353-366.
9. Schwarz H. Biological activities of reverse signal transduction through CD137 ligand. J Leukoc Biol 2005;77:281-286.
10. Lippert U, Zachmann K, Ferrari DM et al. CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response. Eur J Immunol 2008;38:1024-1032.
11. Laderach D, Wesa A, Galy A. 4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12. Cell Immunol 2003;226:37-44.
12. Pauly S, Broll K, Wittmann M et al. CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers. J Leukoc Biol 2002;72:35-42.
13. Lindstedt M, Johansson-Lindbom B, Borrebaeck CA. Expression of CD137 (4-1BB) on human follicular dendritic cells. Scand J Immunol 2003;57:305-310.
14. Langstein J, Michel J, Fritsche J et al. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J Immunol 1998;160:2488-2494.
15. Langstein J, Michel J, Schwarz H. CD137 induces proliferation and endomitosis in monocytes. Blood 1999;94:3161-3168.
16. Langstein J, Becke FM, Sollner L et al. Comparative analysis of CD137 and LPS effects on monocyte activation, survival, and proliferation. Biochem Biophys Res Commun 2000;273:117-122.
17. Langstein J, Schwarz H. Identification of CD137 as a potent monocyte survival factor. J Leukoc Biol 1999;65:829-833.
18. Ju SW, Ju SG, Wang FM et al. A functional anti-human 4-1BB ligand monoclonal antibody that enhances proliferation of monocytes by reverse signaling of 4-1BBL. Hybrid Hybridomics 2003;22:333-338.
19. Drenkard D, Becke FM, Langstein J et al. CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. FASEB J 2007;21:456-463.
20. Dempke W, Von PA, Grothey A et al. Human hematopoietic growth factors: Old lessons and new perspectives. Anticancer Res 2000;20:5155-5164.
21. Gyger M, Stuart RK, Perreault C. Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor. Bone Marrow Transplant 2000;26:1-16.
22. Rader M. Granulocyte colony-stimulating factor use in patients with chemotherapy-induced neutropenia: Clinical and economic benefits. Oncology (Williston Park) 2006;20:16-21.
23. Schwarz H, Blanco FJ, von Kempis J et al. ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood 1996;87:2839-2845.
24. Eaves C, Lambie K. Atlas of Human Hematopoietic Colonies. Vancouver, B.C., Canada: StemCell Technologies Inc, 1995.
25. Fackler MJ, Krause DS, Smith OM et al. Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 1995;85:3040-3047.
26. Michel J, Pauly S, Langstein J et al. Schwarz H. CD137-induced apoptosis is independent of CD95. Immunology 1999;98:42-46.
27. Smith W, Feldmann M, Londei M. Human macrophages induced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production. Eur J Immunol 1998;28:2498-2507.
28. Kim YJ, Li G, Broxmeyer HE. 4-1BB ligand stimulation enhances myeloid dendritic cell maturation from human umbilical cord blood CD34+ progenitor cells. J Hematother Stem Cell Res 2002;11:895-903.
29. Zhu G, Flies DB, Tamada K et al. Progressive depletion of peripheral B lymphocytes in 4-1BB (CD137) ligand/I-Ealpha)-transgenic mice. J Immunol 2001;167:2671-2676.
30. Greil R, Anether G, Johrer K et al. Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: Pathways, targets, and therapeutic tools. J Leukocbiol 2003;74:311-330.
31. Jacobsen SE, Jacobsen FW, Fahlman C et al. TNF-alpha, the great imitator: Role of p55 and p75 TNF receptors in hematopoiesis. STEM CELLS 1994;12(suppl 1):111-126.
32. Nolte MA, Arens R, van OR et al. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nat Immunol 2005;6:412-418.
33. Niu L, Strahotin S, Hewes B et al. Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J Immunol 2007;178:4194-4213.
34. Kwon BS, Hurtado JC, Lee ZH et al. Immune responses in 4-1BB (CD137)-deficient mice. J Immunol 2002;168:5483-5490.